Sweeping review suggests weight-loss drugs’ effect on 175 conditions
The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...
Largest-ever Ozempic and GLP-1 drug study finds they lower risk of 42 health conditions, including heart attacks and Alzheimer’s disease
The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...
IFLScience10h
Not Just For Weight Loss: GLP-1 Drugs May Affect Addiction And Dementia Risk
Over 2 million people were included in new research to test these drugs against 175 different health outcomes.
Ever-Growing USA on MSN11h
Mitolyn Reviews: Is This Purple Peel Exploit Diet Safe For Weight Loss?
Mitolyn is a new dietary supplement that recently hit the market, and is said to be the ultimate weight loss solution. The ...
Today's Dietitian magazine12h
Some Racial and Ethnic Groups May Face Barriers to Obtaining Obesity Medications
Asians, non-Hispanic Blacks and Hispanics were significantly less likely than whites to use obesity-management medications to lower their weight compared with whites, new research suggests. The ...
clinicaltrialsarena14h
Novo Nordisk’s high-dose Wegovy increases weight loss and remains safe
Novo Nordisk's high dose Wegovy (semaglutide) has shown improved weight loss while remaining safe and tolerable.
BMI is wrong way to measure obesity, researchers say — here’s what they recommend instead
A group of 58 researchers is calling for a new, better way to measure obesity and excess body fat that goes beyond BMI.
STAT15h
Former surgeon general: Vaccine-preventable diseases are still a major threat
While we’re unlikely to see a dramatic rise in deaths from vaccine-preventable diseases in the U.S. in the near term, the ...